Ir para o conteúdo principal

United States News Todas as matérias

Todas as matérias desta seção, das mais recentes às mais antigas — página 350 de 371.

Grafa
Health

FibroBiologics files for first human trial of novel psoriasis therapy

FibroBiologics (NASDAQ:FBLG) took a decisive step toward clinical-stage operations on Wednesday, filing an Investigational New Drug (IND) application with the U.S. Food and Drug Administration to begin Phase 1/2 trials for its lead psoriasis candidate, CYPS317.

Leia mais: FibroBiologics files for first human trial of novel psoriasis therapy
Grafa
Technology

SOL strategies revenue climbs 37% as Solana treasury hits CAD$126 million

SOL Strategies (NASDAQ: STKE) reported full-year financial results for the fiscal year ended September 30, 2025, posting revenue of CAD$14.5 million, a 36.7% increase year over year, driven primarily by the expansion of its staking and validator operations within the Solana ecosystem.

Leia mais: SOL strategies revenue climbs 37% as Solana treasury hits CAD$126 million
Grafa
Technology

Taylor Devices hits record Q2 sales as defense orders offset industrial headwinds

Taylor Devices (NASDAQ:TAYD) reported record-breaking financial results for the second quarter of fiscal 2026, as the North Tonawanda-based manufacturer leveraged strong demand from the aerospace and defense sectors to overcome broader economic pressures in its structural and industrial markets.

Leia mais: Taylor Devices hits record Q2 sales as defense orders offset industrial headwinds
Grafa
Health

Axsome jumps as FDA grants priority review for Alzheimer’s agitation drug

Axsome Therapeutics (NASDAQ:AXSM) shares edged higher Wednesday after the U.S. Food and Drug Administration (FDA) granted Priority Review to its supplemental New Drug Application (sNDA) for AXS-05, a treatment targeting the pervasive and distressing agitation associated with Alzheimer’s disease.

Leia mais: Axsome jumps as FDA grants priority review for Alzheimer’s agitation drug
Grafa
Technology

Nvidia taps TSMC for H200 ramp as China demand hits 2 million units

Nvidia Corp. (NASDAQ:NVDA) is scrambling to meet a surge in demand for its high-end H200 artificial intelligence chips from Chinese technology companies, approaching its primary manufacturer, Taiwan Semiconductor Manufacturing (NYSE:TSM) to significantly ramp up production capacity.

Leia mais: Nvidia taps TSMC for H200 ramp as China demand hits 2 million units